tiprankstipranks
Amedisys Inc (AMED)
NASDAQ:AMED

Amedisys (AMED) Technical Analysis

434 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Amedisys Inc’s (AMED) Moving Averages Convergence Divergence (MACD) indicator is 0.93, suggesting Amedisys Inc is a Sell.
Amedisys Inc’s (AMED) 20-Day exponential moving average is 93.87, while Amedisys Inc’s (AMED) share price is $96.13, making it a Buy.
Amedisys Inc’s (AMED) 50-Day exponential moving average is 93.19, while Amedisys Inc’s (AMED) share price is $96.13, making it a Buy.

Amedisys (AMED) Pivot Points

May 21, 2024, 03:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
92.96
93.62
94.03
94.69
95.09
95.75
96.16
Fibonacci
93.62
94.03
94.28
94.69
95.10
95.35
95.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amedisys (AMED) Moving Averages

May 21, 2024, 03:24 AM
Period
Simple
Exponential
MA5
95.34Buy
95.28Buy
MA10
94.86Buy
94.73Buy
MA20
93.32Buy
93.87Buy
MA50
92.69Buy
93.19Buy
MA100
93.39Buy
93.09Buy
MA200
93.32Buy
92.55Buy
Amedisys Inc’s (AMED) 10-Day exponential moving average is 94.73, while Amedisys Inc’s (AMED) share price is $96.13, making it a Buy.
Amedisys Inc’s (AMED) 100-Day exponential moving average is 93.09, while Amedisys Inc’s (AMED) share price is $96.13, making it a Buy.
Amedisys Inc’s (AMED) stock price is $96.13 and Amedisys Inc’s (AMED) 50-day simple moving average is 92.69, creating a Buy signal.
Amedisys Inc’s (AMED) stock price is $96.13 and Amedisys Inc’s (AMED) 100-day simple moving average is 93.39, creating a Buy signal.
Amedisys Inc’s (AMED) stock price is $96.13 and Amedisys Inc’s (AMED) 200-day simple moving average is 93.32, creating a Buy signal.

Amedisys (AMED) Technical Indicators

May 21, 2024, 03:24 AM
Name
Value
Implied Action
RSI (14)
70.26
Sell
STOCH (9,6)
75.75
Neutral
STOCHRSI (14)
79.39
Neutral
MACD (12,26)
0.93
Sell
ADX (14)
32.80
Neutral
Williams %R
-1.07
Sell
CCI (14)
91.68
Neutral
ATR (14)
1.06
-
Ultimate Oscillator
59.36
Neutral
ROC
4.43
Buy
Amedisys Inc’s (AMED) Relative Strength Index (RSI) is 70.26, creating a Sell signal.
Amedisys Inc’s (AMED) Trend Strength Indicator (ADX) is 32.80, creating a Neutral signal.
Amedisys Inc’s (AMED) Commodity Channel Index (CCI) is 91.68, creating a Neutral signal.
Amedisys Inc’s (AMED) Price Rate of Change (ROC) is 4.43, creating a Buy signal.

FAQ

Is AMED a Buy, Hold, or Sell?
Based on AMED’s technical indicators, AMED is a Buy.
    What is AMED’s RSI (14)?
    AMED’s RSI (14) is 70.26, which suggests AMED is a Sell.
      What is AMED’s MACD?
      AMED’s MACD is 0.93, which suggests AMED is a Sell.
        What is AMED’s 5-day moving average?
        AMED’s 5-day moving average is 95.34, which suggests AMED is a Buy.
          What is AMED’s 20-day moving average?
          AMED 20-day moving average is 93.32, which suggests AMED is a Buy.
            What is AMED’s 50-day moving average?
            AMED’s 50-day moving average is 92.69, which suggests AMED is a Buy.
              What is AMED’s 200-day moving average?
              AMED’s 200-day moving average is 93.32, which suggests AMED is a Buy.
                What is AMED’s Williams % R (14)?
                AMED’s Williams % R (14) is -1.07, which suggests AMED is a Sell.
                  What is AMED’s CCI (14)?
                  AMED’s CCI (14) is 91.68, which suggests AMED is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis